Optical genome testing for blood cancer diagnosis
Part of Blood & lymphatic clinical trials.
This study tests a special way of looking at chromosomes to help diagnose blood-related cancers or blood disorders. If you’re having samples taken for chromosome testing, this trial may use your sample to see if the method helps with diagnosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a blood-related condition suspected or confirmed (a “hemopathy”) and a sample is being sent for chromosome/genetics testing.
- You can give consent (or, if you’re a minor, your legal guardian can consent).
- You are not under legal protection such as guardianship or curatorship.
- You are willing to participate—no refusal of participation.
- You will provide the needed sample(s) for the chromosome/genetics laboratory testing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a special eye-based lab test called optical genome mapping can better detect new (acquired) chromosome changes in people with certain slow-growing blood cancers. It may help doctors choose the right next steps based on what’s happening in the bone marrow.
This study looks at gene patterns in people with blood cancers to better understand the disease and find possible treatments. If you are being tested for a blood cancer or have a blood cancer that came back or got worse, you may be able to join.
This study collects and stores blood and bone marrow samples from young people with certain blood cancers so doctors can do genetic (“genomic”) testing now and in the future. It may help improve understanding of the disease and support better matching of care for patients.
This trial tests a new digital microscope system that helps analyze bone marrow samples. If you have a blood disorder and have had a recent bone marrow sample taken, this study can help doctors improve their testing.
This study offers genetic testing to people newly diagnosed with a blood cancer. By comparing the genes in your bone marrow and your skin, doctors hope to learn more about your cancer and find better ways to treat it.
This study uses advanced DNA sequencing to figure out unclear or unusual blood (hematologic) conditions when standard tests are not enough. It may help your care team reach a more accurate diagnosis by better understanding what’s driving your illness.
Hear when a new MDS trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.